Thomas Efferth
German Cancer Research Center
Im Neuenheimer Feld 280
D-69120 Heidelberg
Germany
Name/email consistency: high
- Microarray-based prediction of cytotoxicity of tumor cells to cantharidin. Efferth, T. Oncol. Rep. (2005)
- Molecular modes of action of cantharidin in tumor cells. Efferth, T., Rauh, R., Kahl, S., Tomicic, M., Böchzelt, H., Tome, M.E., Briehl, M.M., Bauer, R., Kaina, B. Biochem. Pharmacol. (2005)
- Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. Efferth, T., Volm, M. In. Vivo (2005)
- Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Efferth, T. Drug Resist. Updat. (2005)
- Pharmacogenetics for individualized cancer chemotherapy. Efferth, T., Volm, M. Pharmacol. Ther. (2005)
- Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Efferth, T., Ramirez, T., Gebhart, E., Halatsch, M.E. Biochem. Pharmacol. (2004)
- Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Efferth, T., Oesch, F. Biochem. Pharmacol. (2004)
- Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia. Efferth, T., Sauerbrey, A., Steinbach, D., Gebhart, E., Drexler, H.G., Miyachi, H., Chitambar, C.R., Becker, C.M., Zintl, F., Humeny, A. Int. J. Oncol. (2003)
- Molecular modes of action of artesunate in tumor cell lines. Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H.O., Hengstler, J.G., Halatsch, M.E., Volm, M., Tew, K.D., Ross, D.D., Funk, J.O. Mol. Pharmacol. (2003)
- Identification of gene expression profiles predicting tumor cell response to L-alanosine. Efferth, T., Gebhart, E., Ross, D.D., Sauerbrey, A. Biochem. Pharmacol. (2003)
- Role of antioxidant genes for the activity of artesunate against tumor cells. Efferth, T., Briehl, M.M., Tome, M.E. Int. J. Oncol. (2003)